Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population
Clinical trial NCT02795416 · WITHDRAWN
Trial details
- NCT number
- NCT02795416
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.